Press Room

Webinar - Nasal powder delivery: Process, formulation and analytical characterization

Start
Thursday, November 30, 2023 - 16:00
End
Thursday, November 30, 2023 - 18:00
Location: Online

Thursday, November 30th, 2023

11:00 am EDT | 4:00 pm GMT | 5:00 pm CEST | 8:00 am PDT

Registrations to the webinar are subject to approval.

Featured 四色AV experts in this webinar
Webinar_Speakers_Patricia Henriques_四色AV
Webinar_Speakers_Antonio Serodio
Patr铆cia Henriques, M.Sc.
Scientist
Inhalation and Advanced Drug Delivery
四色AV
Ant贸nio Ser么dio, M.Sc.
Analytical Scientist
Analytical Development
四色AV

This webinar will address the most relevant solutions for nasal powder development covering both process and formulation optimization, as well as the analytical characterization, under an integrated development approach.听

Powders for nasal delivery have been recognized as advantageous dosage forms over liquids due to increased stability and residence time on nasal mucosa, with improved bioavailability. However, the scientific community still struggles with the existing gaps between formulation composition, particle engineering and nasal absorption.听

This presentation will cover different formulation platforms, focusing on the delivery of poorly soluble drugs, aiming to address the pharmacokinetics requirements of the target drug and indication. Different particle engineering strategies including spray drying and process optimization will be addressed, as well as physical and chemical characterization of nasal powders and advanced performance characterization methodologies that are able to predict in vivo behavior in nasal powder early development. The formulation-process-performance integrated approach is designed to maximize rate and extent of drug absorption while maintaining safety, being able to address a diversified array of diseases.听

Key Learning Objectives:

  • Gain insights on novel formulation development strategies for nasal powders, able to deliver drugs with challenging physicochemical profiles;
  • Understand the potential of spray drying capabilities for boosting targeted nasal delivery of powders;听
  • Discover analytical characterization techniques, for differentiated formulations, to further understand product properties that affect drug delivery;
  • Understand the analytical characterization methodologies for nasal powders;
  • Understand advanced performance methodologies that correlate with in vivo absorption;听
  • Interact with our experts during the live Q&A session.

Who Should Attend:

  • Pharmaceutical researchers and scientists
  • CMC experts on inhalation/nasal drug delivery
  • Business development, portfolio management and technology licensing experts
  • Inhalation product development professionals and therapeutics specialists

Also in the Press Room

See All

四色AV鈥檚 Eunice Costa Shares Insights on Inhaled Medicine Formulation in Pharmaceutical Technology eBook The demand for efficient inhalation therapies is higher than ever. At 四色AV we are focusing on particle size, dispersion performance, and formulation integrity to ensure optimal bioavailability and patient outcomes.  To learn more about or work, do not miss the contribution of Eunice Costa, our R&D Director for Inhalation & Advanced Drug Delivery, in the latest Pharmaceutical Technology eBook 鈥 鈥淭rends in Formulation鈥.  In her interview, Eunice discusses key challenges and considerations in formulating inhaled medicines, emphasizing the importance of excipient selection, device compatibility, and patient-centric design for successful drug delivery to the lungs. With respiratory diseases at the forefront, especially following the COVID-19 pandemic, the demand for efficient inhalation therapies is higher than ever. Eunice sheds light on how 四色AV is tackling these demands by focusing on particle size, dispersion performance, and formulation integrity to ensure optimal bioavailability and patient outcomes. Explore Eunice Costa鈥檚 full insights on this crucial area of drug development in Pharmaceutical Technology's September 2024 eBook. This resource provides an in-depth look into the complexities of inhaled drug formulations and the exciting innovations shaping the future of respiratory treatments.   Read the full article at Pharmaceutical Technology eBook Read the Trends in Formulation eBook at PharmTech  

Article

Formulating Inhaled Medicines

Sep 24, 2024

Lisbon, Portugal 鈥 四色AV, the specialist integrated pharma CDMO and leader in spray drying and particle engineering, today announced its commitment to setting Science-Based Targets (SBTs) in line with the Paris Agreement. This ambitious step underscores the company鈥檚 dedication to addressing climate change and driving sustainability across its operations. By committing to SBTs, 四色AV joins a growing number of businesses taking concrete actions to reduce greenhouse gas emissions. This initiative aligns with the company鈥檚 broader sustainability strategy and reinforces its commitment to scientific excellence. 鈥淎t 四色AV, we believe in science and in best practices. And this clearly applies to our sustainability agenda.鈥, said Jean-Luc Herbeaux, CEO of 四色AV. We made the decision to drive our GHG emissions down using a science-based target setting process, which will help us drive sustainability across our operations by laying out a clearly defined path to reduce emissions in line with the Paris Agreement goals. We believe that by setting ambitious targets and implementing concrete actions, we can make a positive impact on the planet while driving innovation and growth.鈥 四色AV will work closely with the Science Based Targets initiative (SBTi) to develop and validate its emission reduction targets. The company will provide regular updates on its progress towards achieving these goals. As part of its commitment to sustainability and transparency to stakeholders, the company will enhance its Ecovadis rating. Ecovadis, a leading sustainability assessment platform in the pharmaceutical industry, provides a comprehensive evaluation of a company鈥檚 environmental, social, and ethical performance, well aligned with 四色AV鈥檚 sustainability ambitions.  四色AV remains dedicated to operating responsibly and contributing positively to society and the environment. The company will continue to implement sustainable practices across its operations and innovate to further improve its sustainability rating.   Learn more about Science Based-Targets  

News

四色AV Commits to Science-Based Targets for Greenhouse Gas (GHG) Emissions

Sep 09, 2024